NO993911D0 - Remedier/Forebygningsmidler for åndedrettssykdommer - Google Patents
Remedier/Forebygningsmidler for åndedrettssykdommerInfo
- Publication number
- NO993911D0 NO993911D0 NO993911A NO993911A NO993911D0 NO 993911 D0 NO993911 D0 NO 993911D0 NO 993911 A NO993911 A NO 993911A NO 993911 A NO993911 A NO 993911A NO 993911 D0 NO993911 D0 NO 993911D0
- Authority
- NO
- Norway
- Prior art keywords
- group
- respiratory diseases
- remedies
- substituted
- alkyl group
- Prior art date
Links
- 208000023504 respiratory system disease Diseases 0.000 title abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 125000004453 alkoxycarbonyl group Chemical group 0.000 abstract 1
- 125000005115 alkyl carbamoyl group Chemical group 0.000 abstract 1
- 125000003277 amino group Chemical group 0.000 abstract 1
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 abstract 1
- 125000004432 carbon atom Chemical group C* 0.000 abstract 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 abstract 1
- 125000006165 cyclic alkyl group Chemical group 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 125000005843 halogen group Chemical group 0.000 abstract 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 1
- 239000001257 hydrogen Substances 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 230000003449 preventive effect Effects 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 125000000547 substituted alkyl group Chemical group 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
- C07D487/14—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP4721197 | 1997-02-14 | ||
| JP4719797 | 1997-02-14 | ||
| PCT/JP1997/004878 WO1998035968A1 (fr) | 1997-02-14 | 1997-12-26 | Produits therapeutiques/prophylactiques des maladies respiratoires |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO993911D0 true NO993911D0 (no) | 1999-08-13 |
| NO993911L NO993911L (no) | 1999-08-13 |
Family
ID=26387351
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO993911A NO993911L (no) | 1997-02-14 | 1999-08-13 | Remedier/Forebygningsmidler for Õndedrettssykdommer |
Country Status (8)
| Country | Link |
|---|---|
| EP (1) | EP0976754B1 (fr) |
| JP (1) | JP4192250B2 (fr) |
| AT (1) | ATE271051T1 (fr) |
| AU (1) | AU727572B2 (fr) |
| CA (1) | CA2279641A1 (fr) |
| DE (1) | DE69729890T2 (fr) |
| NO (1) | NO993911L (fr) |
| WO (1) | WO1998035968A1 (fr) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7329668B2 (en) | 2003-02-25 | 2008-02-12 | Bristol-Myers Squibb Company | Pyrazolopurine-based tricyclic compounds and pharmaceutical compositions comprising same |
| WO2005087775A1 (fr) * | 2004-03-15 | 2005-09-22 | Ono Pharmaceutical Co., Ltd. | Composé hétérocyclique tricyclique et composition médicinale contenant le composé comme ingrédient actif |
| RU2015143517A (ru) | 2013-03-13 | 2017-04-19 | Дженентек, Инк. | Пиразолсодержащие соединения и их применения |
| CN107001377B (zh) * | 2014-12-08 | 2019-09-10 | 爱尔兰詹森科学公司 | 对呼吸道合胞病毒(rsv)的复制具有抑制活性的哌啶取代的吡唑并[1,5-a]嘧啶衍生物 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0688999B2 (ja) * | 1988-10-13 | 1994-11-09 | ポーラ化成工業株式会社 | ピロロ〔３，２―ｅ〕ピラゾロ〔１，５―ａ〕ピリミジン誘導体およびこれを含有する医薬 |
| JPH07242670A (ja) * | 1994-03-08 | 1995-09-19 | Pola Chem Ind Inc | ピロロ［３，２−ｅ］ピラゾロ［１，５−ａ］ピリミジン誘導体及びこれを含有する循環器系疾患治療剤 |
| JPH07267960A (ja) * | 1994-03-28 | 1995-10-17 | Lederle Japan Ltd | ピロロ［３，２−ｅピラゾロ［１，５−ａピリミジン誘導体及びこれを含有する循環器系疾患治療剤 |
| JPH10218881A (ja) * | 1997-02-03 | 1998-08-18 | Pola Chem Ind Inc | 新規なピロロピラゾロピリミジン誘導体 |
-
1997
- 1997-12-26 AT AT97949248T patent/ATE271051T1/de not_active IP Right Cessation
- 1997-12-26 DE DE69729890T patent/DE69729890T2/de not_active Expired - Fee Related
- 1997-12-26 WO PCT/JP1997/004878 patent/WO1998035968A1/fr not_active Ceased
- 1997-12-26 CA CA002279641A patent/CA2279641A1/fr not_active Abandoned
- 1997-12-26 AU AU87051/98A patent/AU727572B2/en not_active Ceased
- 1997-12-26 EP EP97949248A patent/EP0976754B1/fr not_active Expired - Lifetime
- 1997-12-26 JP JP53555198A patent/JP4192250B2/ja not_active Expired - Fee Related
-
1999
- 1999-08-13 NO NO993911A patent/NO993911L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| AU8705198A (en) | 1998-09-08 |
| EP0976754A4 (fr) | 2001-01-10 |
| CA2279641A1 (fr) | 1998-08-20 |
| ATE271051T1 (de) | 2004-07-15 |
| NO993911L (no) | 1999-08-13 |
| WO1998035968A1 (fr) | 1998-08-20 |
| DE69729890T2 (de) | 2005-07-14 |
| EP0976754A1 (fr) | 2000-02-02 |
| AU727572B2 (en) | 2000-12-14 |
| EP0976754B1 (fr) | 2004-07-14 |
| JP4192250B2 (ja) | 2008-12-10 |
| DE69729890D1 (de) | 2004-08-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20020968D0 (no) | Glukopyranosyloksypyrazolderivater, medisinske sammensetninger inneholdende det samme og intermediater forfremstillingen derav | |
| CY1111951T1 (el) | Φαινυλο-καρβοξαμιδικες ενωσεις χρησιμες για την αντιμετωπιση πονου | |
| NO950297D0 (no) | Prolinamidderivater | |
| PT976748E (pt) | Derivados de pirrolidina com actividade inibidora de fosfolipase a2 | |
| AU4396899A (en) | Remedies for diabetes | |
| IT1311922B1 (it) | Composti farmaceutici. | |
| IL169184A0 (en) | Aromatic compounds as anti-inflammatory, immunomdulatory and anti-proliferatory agents | |
| DE69834500D1 (de) | Xanthinderivative zur behandlung von hirnischämie | |
| BRPI0317188A2 (pt) | Novo derivado de 2,4-diamino-1,3,5-triazina | |
| GR3025568T3 (en) | Medicament for therapeutic and prophylactic treatment of diseases caused by smooth muscle cell hyperplasia. | |
| ATE284684T1 (de) | Amidderivate zur behandlung neurodegenerativer erkrankungen der netzhaut | |
| NO993911L (no) | Remedier/Forebygningsmidler for Õndedrettssykdommer | |
| ATE234086T1 (de) | Creatine derivate für asthma | |
| MY122570A (en) | Benzamide derivatives and drugs containing the same | |
| DE60238847D1 (de) | Pyrimidinderivate enthaltendes medikament |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |